As part of the on-going R&D by Dr. Evans and his team, the PulStar brand has always represented the newest technologies revolutionizing the field of musculoskeletal therapy.
What makes PulStar technologies so revolutionary is the fact that they are based on research that begins at the cellular level. For example, one of Dr. Evans’ more recent studies focused on the origins of atraumatic neuromusculoskeletal pain.
His findings on the subject were published in the Chiropractic Journal of Australia in January, 2016. The theory has broad implications for the improvement of therapeutic modalities, not just for relief from pain, but for the prevention of pain at its origin. Here are some of the elements that contribute to his theory:
- Atraumatic musculoskeletal pain may begin when a muscle contracts, but a failure of the calcium pump prevents the muscle from relaxing
- If this muscle dysfunction is not immediately corrected, it could compromise the lymphatic system, which could result in potentially serious consequences such as localized edema, decreased blood flow, production of abnormal products of cellular metabolism and other potentially serious health effects.
The idea that a muscle being stuck in a contracted state is the underlying cause of atraumatic pain could replace the existing school of thought that this type of pain is a result of tissue injury caused by overuse, buckling or trauma.